MarketPulse

underwritten offering

12 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Syntec Optics Raises $20M via Public Offering to Fund Strategic Growth

Syntec Optics prices $20M public offering of 2.86M shares at $7.00 each to fund acquisitions, capex, and debt reduction, closing April 30, 2026.
OPTXOPTXWdefense technologypublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Oruka Therapeutics Raises $700M in Upsized Public Offering at $72.50 Per Share

Oruka Therapeutics prices 9.66M shares at $72.50 in upsized offering, raising $700.4M with potential additional proceeds from underwriter overallotment option.
ORKAmonoclonal antibodyclinical-stage
BenzingaBenzinga··Not Specified

Oruka Therapeutics Plans $500M Capital Raise via Public Offering

Oruka Therapeutics plans $500M public offering plus $75M underwriter option to fund monoclonal antibody pipeline for psoriasis and inflammatory conditions.
ORKAmonoclonal antibodypublic offering
BenzingaBenzinga··Prnewswire

Velo3D Raises $50M Through Direct Stock Offering to Fund Operations

Metal 3D printing firm Velo3D prices $50M registered direct offering at $14 per share, closing April 28, 2026.
VELOcommon stockcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Maze Therapeutics Raises $150M to Fund Late-Stage Drug Pipeline Through 2029

Maze Therapeutics prices $150M offering at $23.50/share, securing funding through 2029 for kidney disease and PKU programs.
MAZEclinical developmentcapital raise
BenzingaBenzinga··Globe Newswire

Spyre Therapeutics Raises $300M in IPO as IBD-Focused Biotech Advances Pipeline

Clinical-stage biotech Spyre Therapeutics launches $300M public offering to fund inflammatory bowel disease drug development, with major investment banks leading.
SYREpublic offeringcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Spyre Therapeutics Raises $300M in IPO to Fund IBD Drug Development

Clinical-stage biotech Spyre Therapeutics announced $300M public offering with $45M underwriter option, led by Jefferies and Goldman Sachs, targeting IBD treatments.
SYREpublic offeringcapital raise
BenzingaBenzinga··Na

NUAI Launches Public Stock Offering to Refinance SharonAI Debt

New Era Energy & Digital announces underwritten public offering to repay convertible note to SharonAI, with Northland Capital Markets as lead manager.
NUAINUAIWSHAZdebt repaymentpublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Calidi Biotherapeutics Raises $6M in Public Offering, Exercises Full Warrant Overallotment

Calidi Biotherapeutics closed a $6 million underwritten public offering, issuing 12.1 million shares and Series J, K, L warrants with $0.50 exercise prices.
CLDIwarrantspublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Realloys Inc.

REalloys Prices $50M Stock Offering to Fund Operations

REalloys Inc. ($ALOY) prices upsized $50M public offering at $18.50/share, with proceeds designated for working capital and general corporate purposes.
ALOYpublic offeringcapital raising
BenzingaBenzinga··Globe Newswire

REalloys Eyes Capital Raise Via Stock Offering Amid Rare Earth Push

REalloys announces underwritten public stock offering with Clear Street, Needham & Company as lead managers to fund operations and general corporate needs.
ALOYworking capitalpublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Prices $6.4M Unit Offering at $0.20 Per Share

Blue Hat Interactive prices $6.4M unit offering at $0.20 per share. Each unit includes one ordinary share and one warrant, with proceeds for working capital.
BHATpublic offeringcapital raising